Trial · NCT01078909
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 300mg Fish Oil (EPA + DHA) Supplement | TNF-alpha (pg/mL) | 1.4 | 95% Confidence Interval 1.3 to 1.5 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 600mg Fish Oil (EPA+DHA) Supplement | TNF-alpha (pg/mL) | 1.3 | 95% Confidence Interval 1.1 to 1.5 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 900mg Fish Oil (EPA + DHA) Supplement | TNF-alpha (pg/mL) | 1.4 | 95% Confidence Interval 1.2 to 1.5 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 1800mg Fish Oil (EPA + DHA) Supplement | TNF-alpha (pg/mL) | 1.5 | 95% Confidence Interval 1.2 to 1.6 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | Placebo | TNF-alpha (pg/mL) | 1.4 | 95% Confidence Interval 1.1 to 1.6 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 300mg Fish Oil (EPA + DHA) Supplement | IL-6 (pg/mL) | 0.9 | 95% Confidence Interval 0.7 to 1.1 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 600mg Fish Oil (EPA+DHA) Supplement | IL-6 (pg/mL) | 1 | 95% Confidence Interval 0.8 to 1.2 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 900mg Fish Oil (EPA + DHA) Supplement | IL-6 (pg/mL) | 0.9 | 95% Confidence Interval 0.7 to 1.1 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | 1800mg Fish Oil (EPA + DHA) Supplement | IL-6 (pg/mL) | 1 | 95% Confidence Interval 0.8 to 1.2 | pg/mL |
| Mean Concentrations of Inflammatory Markers (TNF-alpha and IL-6) Following 5 Months of Treatment | Placebo | IL-6 (pg/mL) | 0.9 | 95% Confidence Interval 0.7 to 1.1 | pg/mL |
| Mean Concentrations of CRP Following 5 Months of Treatment | 300mg Fish Oil (EPA + DHA) Supplement | 0.6 | 95% Confidence Interval 0.4 to 1.1 | mg/dL | |
| Mean Concentrations of CRP Following 5 Months of Treatment | 600mg Fish Oil (EPA+DHA) Supplement | 0.5 | 95% Confidence Interval 0.3 to 0.6 | mg/dL | |
| Mean Concentrations of CRP Following 5 Months of Treatment | 900mg Fish Oil (EPA + DHA) Supplement | 0.6 | 95% Confidence Interval 0.4 to 1.0 | mg/dL | |
| Mean Concentrations of CRP Following 5 Months of Treatment | 1800mg Fish Oil (EPA + DHA) Supplement | 0.6 | 95% Confidence Interval 0.4 to 0.9 | mg/dL | |
| Mean Concentrations of CRP Following 5 Months of Treatment | Placebo | 0.5 | 95% Confidence Interval 0.3 to 0.8 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01078909/results